SUMMARY Clinical examination of 33 consecutive newly diagnosed cases of Steele-RichardsonOlszewski syndrome revealed evidence of cognitive impairment in 20. Eighteen of the 27 right handed patients who underwent neuropsychological assessment had intellectual impairment (mild in nine and marked in nine patients). The pattern of abnormalities was similar to but more severe than those previously reported in Parkinson's disease, with particular difficulties in carrying out tests which are believed to be sensitive to frontal lobe dysfunction.
In 1964, Steele, Richardson and Olszewski' reported the neuropathological and clinical features of a previously unrecognised syndrome which they called Progressive Supranuclear Palsy. Dementia, usually mild, was present in seven of the original nine patients and the presence of cognitive deficits and personality change have subsequently been confirmed.27 However, the exact frequency, severity and type of neuropsychological impairment is still controversial. Most studies have relied on clinical examination or impression to diagnose dementia and a large series of consecutive patients has never been studied. In studies in which neuropsychological testing has been carried out it has been claimed that the performance of patients with the SteeleRichardson-Olszewski (SRO) syndrome was only impaired on tests requiring visual scanning ability and that otherwise there was no evidence of intellectual or memory impairment.89 We therefore reviewed the neuropsychological reports in a group of newly diagnosed cases of SRO syndrome seen at the National Hospitals for Nervous Diseases between 1975 and 1984 to determine the incidence and extent of intellectual impairment.
Methods
The clinical records of 33 consecutive admissions to the National Hospitals for Nervous Diseases with a new diag-nosis of SRO syndrome were reviewed retrospectively. All patients had unequivocal evidence of the syndrome, with supranuclear palsy affecting at least downgaze and some or all of the following features: pseudobulbar palsy, axial and/or limb rigidity, bradykinesia, dementia, pyramidal signs and gait disorder. Neuropsychological assessment was performed on 29 patients, of whom 27 were known to be right-handed and these were selected for further examination. These 27 (7), depression (6) and slower mentation (4) . Personality changes were reported by the relatives of four patients (apathetic or withdrawn: four patients, irritability in one patient).
Evidence of intellectual impairment and memory disturbance was considered to be present on clinical examination in 17 of the 27 patients. Clinical examination of the four patients who were not neuropsychologically assessed showed evidence of intellectual impairment in three (marked in two, mild in one patient).
Eight of the 27 patients were receiving neurotropic medication at the time of neuropsychological assessment (levodopa and decarboxylase inhibitor preparation six patients, benzhexol three patients and amantadine one patient).
CT scans were performed on all patients and showed evidence of cerebral atrophy and ventricular dilatation in 23 of the 27 patients (mild in 15 patients, moderate in seven patients and marked in one patient).
Seventeen patients had had an EEG recorded. None of the records were markedly abnormal. Eight records were normal, six were mildly abnormal (slight slowing or low amplitude alpha rhythm, minor scattered theta activity) and three were more notably abnormal (two showed asymmetrical excess theta activity and one showed nonspecific frontal theta activity on hyperventilation. Results 
WAIS testing
The mean reading, verbal, performance and fullscale IQ scores are given in table 1. For the patients who completed both tests, there was a significant difference between the NART and verbal IQ scores (n = 19 t = 4-46 p < 0-001), the NART and Performance IQ scores (n = 16 t = 6-76 p < 0-001), the NART and full scale IQ scores (n = 17 t = 6.68 p < 0-001) and the verbal and performance IQ scores (n = 20 t = 3.74 p < 0-001).
The discrepancy between the NART and the Full-scale IQ (calculated from the verbal IQ for the three patients who had not attempted the performance scale) score was recorded as an index of deterioration in 19 patients. The mean (+SD) discrepancy was 13 3 (+10-1), six patients were consi- 
